Lexicon Pharmaceuticals
LXRX • NASDAQ
Lexicon Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael S. Exton, with a market cap of $745.7M.
Market Cap$745.7M
Employees285.0
CEOMichael S. Exton
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Lexicon Pharmaceuticals FAQ
Common questions about Lexicon Pharmaceuticals
Lexicon Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $9.4M.
Lexicon Pharmaceuticals has approximately 285 employees.